Latent tuberculosis: What the host "sees"?

Immunologic Research

Volumn 50, Issue 2-3, 2011, Pages 202-212

  Gideon, Hannah P ^a   Flynn, Joanne L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Latent tuberculosis; Mycobacterium tuberculosis infection; Non human Primate models; Tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INFLIXIMAB; INTERLEUKIN 17; INTERLEUKIN 2; ISONIAZID; NITRIC OXIDE; TUBERCULIN; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; BACTERIAL CELL WALL; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; GENE CONTROL; GRANULOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INFECTION CONTROL; LATENT TUBERCULOSIS; LUNG LAVAGE; LYMPH NODE; MACROPHAGE FUNCTION; MEMORY CELL; MONOTHERAPY; NEUTROPHIL; NONHUMAN; PH; PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR; SHORT COURSE THERAPY; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN TEST; TH1 CELL; TREATMENT DURATION; TREATMENT RESPONSE; VACCINATION;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; GRANULOMA; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; LATENT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIMATES; T-LYMPHOCYTES;

EID: 79961172115     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-011-8229-7     Document Type: Article

References (110)

1. WHO 2010 Global tuberculosis control: key findings from the December 2009 WHO report Wkly Epidemiol Rec 85 9 69 80
2. TM Daniel 2006 The history of tuberculosis Respir Med 100 11 1862 1870 16949809 (Pubitemid 44490295)
3. BB Trunz P Fine C Dye 2006 Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness Lancet 367 9517 1173 1180 16616560
4. V Walker G Selby I Wacogne 2006 Does neonatal BCG vaccination protect against tuberculous meningitis? Arch Dis Child 91 9 789 791 16923863 1:STN:280:DC%2BD28vpvVCrsw%3D%3D (Pubitemid 44351186)
5. GA Colditz TF Brewer CS Berkey ME Wilson E Burdick HV Fineberg F Mosteller 1994 Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature JAMA 271 9 698 702 8309034 1:STN:280:DyaK2c7kt1Sqsg%3D%3D (Pubitemid 24061706)
6. TF Brewer 2000 Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature Clin Infect Dis 31 Suppl 3 S64 S67 11010824
7. MA Behr PM Small 1997 Has BCG attenuated to impotence? Nature 389 6647 133 134 9296487 1:CAS:528:DyaK2sXmtVSlu7Y%3D
8. MA Behr MA Wilson WP Gill H Salamon GK Schoolnik S Rane PM Small 1999 Comparative genomics of BCG vaccines by whole-genome DNA microarray Science 284 5419 1520 1523 10348738 1:CAS:528:DyaK1MXjs1Wjtbw%3D
9. SV Gordon K Eiglmeier T Garnier R Brosch J Parkhill B Barrell ST Cole RG Hewinson 2001 Genomics of Mycobacterium bovis Tuberculosis (Edinb) 81 1-2 157 163 1:STN:280:DC%2BD3MvhsVyhtw%3D%3D (Pubitemid 32500102)
10. GG Mahairas PJ Sabo MJ Hickey DC Singh CK Stover 1996 Molecular analysis of genetic differences between Mycobacterium bovis BCG, virulent M. bovis J Bacteriol 178 5 1274 1282 8631702 1:CAS:528:DyaK28XhsVSqur4%3D (Pubitemid 26073382)
11. R Brosch SV Gordon M Marmiesse, et al. 2002 A new evolutionary scenario for the Mycobacterium tuberculosis complex Proc Natl Acad Sci U S A 99 6 3684 3689 11891304 1:CAS:528:DC%2BD38Xis1KlsbY%3D (Pubitemid 34252166)
12. I Knezevic MJ Corbel 2006 WHO discussion on the improvement of the quality control of BCG vaccines Vaccine 24 18 3874 3877 16755681 1:CAS:528:DC%2BD28XksFaquro%3D
13. N Ritz WA Hanekom R Robins-Browne WJ Britton N Curtis 2008 Influence of BCG vaccine strain on the immune response and protection against tuberculosis FEMS Microbiol Rev 32 5 821 841 18616602 1:CAS:528:DC%2BD1cXhtFeiurnI
14. G Maartens RJ Wilkinson 2007 Tuberculosis Lancet 370 9604 2030 2043 17719083 (Pubitemid 350236315)
15. DG Russell CE Barry 3rd JL Flynn 2010 Tuberculosis: what we don't know can, and does, hurt us Science 328 5980 852 856 20466922 1:CAS:528: DC%2BC3cXlvVelt7g%3D
16. M Pai A Zwerling D Menzies 2008 Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update Ann Intern Med 149 3 177 184 18593687
17. M Pai J Minion H Sohn A Zwerling MD Perkins 2009 Novel and improved technologies for tuberculosis diagnosis: progress and challenges Clin Chest Med 30 4 701 716 19925962 viii
18. A Lalvani M Pareek 2009 A 100 year update on diagnosis of tuberculosis infection Br Med Bull 93 69 84 19926636
19. C Lange T Mori 2010 Advances in the diagnosis of tuberculosis Respirology 15 2 220 240 20199641
20. MX Rangaka KA Wilkinson R Seldon, et al. 2007 Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection Am J Respir Crit Care Med 175 5 514 520 17158278 (Pubitemid 46354256)
21. A Lalvani M Pareek 2009 Interferon gamma release assays: principles and practice Enferm Infecc Microbiol Clin 28 245 252 19783328
22. H Herzog 1998 History of tuberculosis Respiration 65 1 5 15 9523361 1:CAS:528:DyaK1cXhsFSjsro%3D (Pubitemid 28076118)
23. CE Barry 3rd HI Boshoff V Dartois, et al. 2009 The spectrum of latent tuberculosis: rethinking the biology and intervention strategies Nat Rev Microbiol 7 12 845 855 19855401 1:CAS:528:DC%2BD1MXhtlSqsLbN
24. PL Lin JL Flynn 2010 Understanding latent tuberculosis: a moving target J Immunol 185 1 15 22 20562268 1:CAS:528:DC%2BC3cXns1Crurc%3D
25. DB Young HP Gideon RJ Wilkinson 2009 Eliminating latent tuberculosis Trends Microbiol 17 5 183 188 19375916 1:CAS:528:DC%2BD1MXls12hsbc%3D
26. L Mtei M Matee O Herfort, et al. 2005 High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania Clin Infect Dis 40 10 1500 1507 15844073 (Pubitemid 40628639)
27. Flynn JL, Chan J, Lin PL. Macrophages and control of granulomatous inflammation in tuberculosis. Mucosal Immunol 2011.
28. PL Lin M Rodgers L Smith, et al. 2009 Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model Infect Immun 77 10 4631 4642 19620341 1:CAS:528:DC%2BD1MXht1Ghu7nO
29. PL Lin S Pawar A Myers, et al. 2006 Early events in Mycobacterium tuberculosis infection in cynomolgus macaques Infect Immun 74 7 3790 3803 16790751 1:CAS:528:DC%2BD28Xms1Wksbg%3D (Pubitemid 43993310)
30. SV Capuano 3rd DA Croix S Pawar, et al. 2003 Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection Infect Immun 71 10 5831 5844 14500505 1:CAS:528:DC%2BD3sXnslyltbg%3D (Pubitemid 37205637)
31. LE Via PL Lin SM Ray, et al. 2008 Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates Infect Immun 76 6 2333 2340 18347040 1:CAS:528:DC%2BD1cXms1egtbY%3D
32. Canetti G. The Tubercule bacillus. Inc, New York: Springer Publishing Co; 1955.
33. HM Loomis 1890 Some facts in the etiology of tuberculosis, evidenced by thirty autopsies and experiments upon animals Medical Record 38 689 698
34. J Opie EaA 1927 Tubercle bacilli in latent tuberculous lesions and lung tissue without tuberculous lesions Arch Pathol 4 1 21
35. AD Griffith 1929 Types of tubercle bacilli in human tuberculosis J Pathol Bacteriol 32 813 840
36. HM Vandiviere 1956 The treated pulmonary lesion and its tubercle bacillus II. The death and resurrection Am J Med Sci 232 30 37 13326887 1:STN:280:DyaG28%2FnvFCkuw%3D%3D
37. PJ Cardona 2007 New insights on the nature of latent tuberculosis infection and its treatment Inflamm Allergy Drug Targets 6 1 27 39 17352686 1:CAS:528:DC%2BD2sXjtlWhsLY%3D
38. LG Wayne CD Sohaskey 2001 Nonreplicating persistence of mycobacterium tuberculosis Annu Rev Microbiol 55 139 163 11544352 1:CAS:528: DC%2BD3MXnslKjt7w%3D (Pubitemid 32978103)
39. GR Stewart BD Robertson DB Young 2003 Tuberculosis: a problem with persistence Nat Rev Microbiol 1 2 97 105 15035039 1:CAS:528:DC%2BD3sXosl2hsrw%3D
40. JE Gomez M McKinney JD 2004 tuberculosis persistence, latency, and drug tolerance Tuberculosis (Edinb) 84 1-2 29 44 (Pubitemid 38082931)
41. Y Zhang 2004 Persistent and dormant tubercle bacilli and latent tuberculosis Front Biosci 9 1136 1156 14977534 1:CAS:528:DC%2BD2cXhtFGjsr8%3D (Pubitemid 39060834)
42. HI Boshoff CE Barry 3rd 2005 Tuberculosis - metabolism and respiration in the absence of growth Nat Rev Microbiol 3 1 70 80 15608701 1:CAS:528: DC%2BD2cXhtVyqtrnE (Pubitemid 40028470)
43. S Ehlers 2009 Lazy, dynamic or minimally recrudescent? On the elusive nature and location of the mycobacterium responsible for latent tuberculosis Infection 37 2 87 95 19308316 1:CAS:528:DC%2BD1MXltlKqsLY%3D
44. CL Cosma DR Sherman L Ramakrishnan 2003 The secret lives of the pathogenic mycobacteria Annu Rev Microbiol 57 641 676 14527294 1:CAS:528:DC%2BD3sXptFWls78%3D (Pubitemid 37392957)
45. JC Betts PT Lukey LC Robb RA McAdam K Duncan 2002 Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling Mol Microbiol 43 3 717 731 11929527 1:CAS:528:DC%2BD38XitlWhurk%3D (Pubitemid 34597265)
46. BA Roxas Q Li 2009 Acid stress response of a mycobacterial proteome: insight from a gene ontology analysis Int J Clin Exp Med 2 4 309 328 20057975 1:CAS:528:DC%2BD1MXhsVOgur3F
47. TR Rustad MI Harrell R Liao DR Sherman 2008 The enduring hypoxic response of Mycobacterium tuberculosis PLoS One 3 1 e1502 18231589
48. GR Stewart L Wernisch R Stabler JA Mangan J Hinds KG Laing DB Young PD Butcher 2002 Dissection of the heat-shock response in Mycobacterium tuberculosis using mutants and microarrays Microbiology 148 Pt 10 3129 3138 12368446 1:CAS:528:DC%2BD38XotFymtLs%3D (Pubitemid 35243712)
49. TR Rustad AM Sherrid KJ Minch DR Sherman 2009 Hypoxia: a window into Mycobacterium tuberculosis latency Cell Microbiol 11 8 1151 1159 19388905 1:CAS:528:DC%2BD1MXovFemu74%3D
50. PK Rao GM Rodriguez I Smith Q Li 2008 Protein dynamics in iron-starved Mycobacterium tuberculosis revealed by turnover and abundance measurement using hybrid-linear ion trap-Fourier transform mass spectrometry Anal Chem 80 18 6860 6869 18690695 1:CAS:528:DC%2BD1cXps1Citbg%3D
51. AK Kesavan M Brooks J Tufariello J Chan YC Manabe 2009 Tuberculosis genes expressed during persistence and reactivation in the resistant rabbit model Tuberculosis (Edinb) 89 1 17 21 1:CAS:528:DC%2BD1MXjtVyit70%3D
52. MY Lin TH Ottenhoff 2008 Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection Biol Chem 389 5 497 511 18953716 1:CAS:528:DC%2BD1cXls1aitrc%3D (Pubitemid 351874191)
53. GF Black BA Thiel MO Ota, et al. 2009 Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa Clin Vaccine Immunol 16 8 1203 1212 19553548 1:CAS:528:DC%2BD1MXhsVCltr%2FI
54. A Demissie EM Leyten M Abebe, et al. 2006 Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis Clin Vaccine Immunol 13 2 179 186 16467323 1:CAS:528:DC%2BD28Xhs1Gmsb4%3D (Pubitemid 43383784)
55. EM Leyten MY Lin KL Franken, et al. 2006 Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis Microbes Infect 8 8 2052 2060 16931093 1:CAS:528: DC%2BD28XpsVOlsr0%3D (Pubitemid 44311602)
56. V Roupie M Romano L Zhang, et al. 2007 Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice Infect Immun 75 2 941 949 17145953 1:CAS:528:DC%2BD2sXhs1ahsLc%3D (Pubitemid 46203459)
57. RJ Wilkinson KA Wilkinson KA De Smet K Haslov G Pasvol M Singh I Svarcova J Ivanyi 1998 Human T- and B-cell reactivity to the 16 kDa alpha-crystallin protein of Mycobacterium tuberculosis Scand J Immunol 48 4 403 409 9790311 1:CAS:528:DyaK1cXntFCktr8%3D (Pubitemid 28459658)
58. A Geluk MY Lin KE van Meijgaarden EM Leyten KL Franken TH Ottenhoff T Klein MR 2007 cell recognition of the HspX protein of Mycobacterium tuberculosis correlates with latent M. tuberculosis infection but not BCG vaccination Infect Immun 75 2914 2921 17387166 1:CAS:528:DC%2BD2sXmtlKmsL8%3D (Pubitemid 46870172)
59. KA Wilkinson GR Stewart SM Newton, et al. 2005 Infection biology of a novel alpha-crystallin of Mycobacterium tuberculosis: Acr2 J Immunol 174 7 4237 4243 15778386 1:CAS:528:DC%2BD2MXisVChtr8%3D (Pubitemid 40396004)
60. HP Gideon KA Wilkinson TR Rustad, et al. 2010 Hypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccines PLoS Pathog 6 12 e1001237 21203487 1:CAS:528:DC%2BC3MXjvVWjsg%3D%3D
61. MJ Smieja CA Marchetti DJ Cook FM Smaill 2000 Isoniazid for preventing tuberculosis in non-HIV infected persons Cochrane Database Syst Rev 2 CD001363 10796642
62. VN Houk DC Kent K Sorensen JH Baker 1968 The eradication of tuberculosis infection by isoniazid chemoprophylaxis Arch Environ Health 16 1 46 50 5638224 1:STN:280:DyaF1c7jsFOrtQ%3D%3D
63. FW Mount SH Ferebee 1962 The effect of isoniazid prophylaxis on tuberculosis morbidity among household contacts of previously known cases of tuberculosis Am Rev Respir Dis 85 821 827 14476668 1:STN:280: DyaF38%2FnvVWmug%3D%3D
64. SH Ferebee FW Mount 1962 Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts Am Rev Respir Dis 85 490 510 13892318 1:STN:280:DyaF38%2FjtlKntw%3D%3D
65. GJ Veening 1968 Long term isoniazid prophylaxis. Controlled trial on INH prophylaxis after recent tuberculin conversion in young adults Bull Int Union Tuberc 41 169 171 4885378 1:STN:280:DyaF1M7htlanuw%3D%3D
66. Ford CB, Lin PL, Chase MR, et al. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat Genet. 2011.
67. CM Yang CH Hsu CM Lee FC Wang 2003 Intense uptake of [F-18]-fluoro-2 deoxy-d-glucose in active pulmonary tuberculosis Ann Nucl Med 17 5 407 410 12971641
68. T Hara N Kosaka T Suzuki K Kudo H Niino 2003 Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study Chest 124 3 893 901 12970014 1:CAS:528:DC%2BD3sXnvF2ksLk%3D (Pubitemid 37123306)
69. JM Goo JG Im KH Do JS Yeo JB Seo HY Kim JK Chung 2000 Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases Radiology 216 1 117 121 10887236 1:STN:280:DC%2BD3czksl2lsg%3D%3D (Pubitemid 30434730)
70. AM Cooper 2009 Cell-mediated immune responses in tuberculosis Annu Rev Immunol 27 393 422 19302046 1:CAS:528:DC%2BD1MXlsFSltrs%3D
71. AM Cooper SA Khader 2008 The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis Immunol Rev 226 191 204 19161425 1:CAS:528:DC%2BD1MXhsFGls7%2FO
72. JT Mattila CR Diedrich PL Lin J Phuah JL Flynn 2011 Simian immunodeficiency virus-induced changes in T cell cytokine responses in cynomolgus macaques with latent Mycobacterium tuberculosis infection are associated with timing of reactivation J Immunol 186 6 3527 3537 21317393 1:CAS:528:DC%2BC3MXisl2qurc%3D
73. WA Hanekom B Abel TJ Scriba 2007 Immunological protection against tuberculosis S Afr Med J 97 10 Pt 2 973 977 18000583 (Pubitemid 350027952)
74. MJ Newport CM Huxley S Huston CM Hawrylowicz BA Oostra R Williamson M Levin 1996 A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection N Engl J Med 335 26 1941 1949 8960473 1:CAS:528:DyaK2sXivVajsg%3D%3D (Pubitemid 26428218)
75. J Keane S Gershon RP Wise E Mirabile-Levens J Kasznica WD Schwieterman JN Siegel MM Braun 2001 Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent N Engl J Med 345 15 1098 1104 11596589 1:CAS:528:DC%2BD3MXnsFShsr0%3D
76. KA Millington JA Innes S Hackforth, et al. 2007 Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load J Immunol 178 8 5217 5226 17404305 1:CAS:528: DC%2BD2sXjslWjt7Y%3D (Pubitemid 46595306)
77. N Caccamo G Guggino SA Joosten, et al. 2010 Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection Eur J Immunol 40 8 2211 2220 20540114 1:CAS:528:DC%2BC3cXpsF2rs7k%3D
78. JS Sutherland IM Adetifa PC Hill RA Adegbola MO Ota 2009 Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease Eur J Immunol 39 3 723 729 19224636 1:CAS:528:DC%2BD1MXktVaisLs%3D
79. CL Day N Mkhwanazi S Reddy Z Mncube M van der Stok P Klenerman BD Walker 2008 Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons J Infect Dis 197 7 990 999 18419535 1:CAS:528:DC%2BD1cXkvFOhtb4%3D (Pubitemid 351590027)
80. KA Wilkinson R Seldon G Meintjes MX Rangaka WA Hanekom G Maartens RJ Wilkinson 2009 Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis Am J Respir Crit Care Med 180 7 674 683 19628776 1:CAS:528:DC%2BD1MXht12gsLfJ
81. RA Seder PA Darrah M Roederer 2008 T-cell quality in memory and protection: implications for vaccine design Nat Rev Immunol 8 4 247 258 18323851 1:CAS:528:DC%2BD1cXjs1antLk%3D (Pubitemid 351432801)
82. SA Khader AM Cooper 2008 IL-23 and IL-17 in tuberculosis Cytokine 41 2 79 83 18218322 1:CAS:528:DC%2BD1cXhsl2gt7Y%3D
83. AM Cooper 2010 Editorial: be careful what you ask for: is the presence of IL-17 indicative of immunity? J Leukoc Biol 88 2 221 223 20679070 1:CAS:528:DC%2BC3cXhtVeisb%2FM
84. MP Berry CM Graham FW McNab, et al. 2010 An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis Nature 466 7309 973 977 20725040 1:CAS:528:DC%2BC3cXhtVyks7bN
85. AM Green JT Mattila CL Bigbee KS Bongers PL Lin JL Flynn 2010 CD4(+) regulatory T cells in a cynomolgus macaque model of Mycobacterium tuberculosis infection J Infect Dis 202 4 533 541 20617900 1:CAS:528:DC%2BC3cXhtVylu7nP
86. S Burl PC Hill DJ Jeffries, et al. 2007 FOXP3 gene expression in a tuberculosis case contact study Clin Exp Immunol 149 1 117 122 17465993 1:CAS:528:DC%2BD2sXovFKktL0%3D (Pubitemid 46897109)
87. SH Kaufmann 2001 How can immunology contribute to the control of tuberculosis? Nat Rev Immunol 1 1 20 30 11905811 1:CAS:528:DC%2BD38XlvF2qtLs%3D (Pubitemid 33741972)
88. MC Tsai S Chakravarty G Zhu, et al. 2006 Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension Cell Microbiol 8 2 218 232 16441433 1:CAS:528:DC%2BD28XhsFant7o%3D (Pubitemid 43356045)
89. PJ Maglione J Chan 2009 How B cells shape the immune response against Mycobacterium tuberculosis Eur J Immunol 39 3 676 686 19283721 1:CAS:528:DC%2BD1MXktVais7c%3D
90. J Maertzdorf D Repsilber SK Parida K Stanley T Roberts G Black G Walzl SH Kaufmann 2011 Human gene expression profiles of susceptibility and resistance in tuberculosis Genes Immun 12 1 15 22 20861863 1:CAS:528:DC%2BC3MXot1OjtA%3D%3D
91. M Jacobsen D Repsilber A Gutschmidt A Neher K Feldmann HJ Mollenkopf A Ziegler SH Kaufmann 2007 Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis J Mol Med 85 6 613 621 17318616 1:CAS:528:DC%2BD2sXmtVGjurk%3D (Pubitemid 46876510)
92. G Walzl K Ronacher W Hanekom TJ Scriba A Zumla 2011 Immunological biomarkers of tuberculosis Nat Rev Immunol 11 5 343 354 21475309 1:CAS:528:DC%2BC3MXksVCqtrk%3D
93. J Keane 2004 Tumor necrosis factor blockers and reactivation of latent tuberculosis Clin Infect Dis 39 3 300 302 15306994 1:CAS:528: DC%2BD2cXnsFSmt7s%3D (Pubitemid 39050475)
94. RS Wallis 2009 Infectious complications of tumor necrosis factor blockade Curr Opin Infect Dis 22 4 403 409 19491672 1:CAS:528:DC%2BD1MXnvVOnsbs%3D
95. PL Lin A Myers L Smith, et al. 2010 Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model Arthritis Rheum 62 2 340 350 20112395 1:CAS:528:DC%2BC3cXhtFGnu77K
96. EL Corbett T Bandason YB Cheung, et al. 2007 Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease PLoS Med 4 1 e22 17199408
97. Lawn SD, Wood R, Wilkinson RJ. Changing concepts of "latent tuberculosis infection" in patients living with HIV infection. Clin Dev Immunol. 2011.
98. B Kalsdorf TJ Scriba K Wood, et al. 2009 HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria Am J Respir Crit Care Med 180 12 1262 1270 19797156 1:CAS:528:DC%2BC3cXmt1Sgsw%3D%3D
99. CR Diedrich JT Mattila E Klein, et al. 2010 Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load PLoS One 5 3 e9611 20224771
100. BM Kagina B Abel M Bowmaker, et al. 2009 Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response Vaccine 27 40 5488 5495 19616494 1:CAS:528:DC%2BD1MXpvFyqsLg%3D
101. AC Hesseling BJ Marais RP Gie HS Schaaf PE Fine P Godfrey-Faussett N Beyers 2007 The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children Vaccine 25 1 14 18 16959383 (Pubitemid 44855247)
102. AC Hesseling H Rabie BJ Marais, et al. 2006 Bacille Calmette-Guerin vaccine-induced disease in HIV-infected and HIV-uninfected children Clin Infect Dis 42 4 548 558 16421800 1:STN:280:DC%2BD28%2Fjt12jtA%3D%3D (Pubitemid 43202529)
103. WHO 2007 Revised BCG vaccination guidelines for infants at risk for HIV infection Wkly Epidemiol Rec 82 21 193 196
104. G Delogu G Fadda 2009 The quest for a new vaccine against tuberculosis J Infect Dev Ctries 3 1 5 15 19749443
105. PH Lambert T Hawkridge WA Hanekom 2009 New vaccines against tuberculosis Clin Chest Med 30 4 811 826 19925969 x
106. WA Hanekom SD Lawn K Dheda A Whitelaw 2010 Tuberculosis research update Trop Med Int Health 15 8 981 989 20561306 1:STN:280:DC%2BC3cnnvVKnsw%3D%3D
107. C Aagaard T Hoang J Dietrich, et al. 2011 A multistage tuberculosis vaccine that confers efficient protection before and after exposure Nat Med 17 2 189 194 21258338 1:CAS:528:DC%2BC3MXps1ajsg%3D%3D
108. C Akolo I Adetifa S Shepperd J Volmink 2010 Treatment of latent tuberculosis infection in HIV infected persons Cochrane Database Syst Rev 1 CD000171 20091503
109. D Menzies H Al Jahdali B Al Otaibi 2011 Recent developments in treatment of latent tuberculosis infection Indian J Med Res 133 3 257 266 21441678 1:CAS:528:DC%2BC3MXlvVeju7w%3D
110. P Lobue D Menzies 2010 Treatment of latent tuberculosis infection: an update Respirology 15 4 603 622 20409026